RT Book, Section A1 Jackman, David M. A1 Cioffredi, Leigh-Anne A2 Sugarbaker, David J. A2 Bueno, Raphael A2 Colson, Yolonda L. A2 Jaklitsch, Michael T. A2 Krasna, Mark J. A2 Mentzer, Steven J. A2 Williams, Marcia A2 Adams, Ann SR Print(0) ID 1105845104 T1 Systemic Chemotherapy for Mesothelioma T2 Adult Chest Surgery, 2e YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 978-0-07-178189-3 LK accesssurgery.mhmedical.com/content.aspx?aid=1105845104 RD 2024/10/12 AB Mesothelioma is a rare malignancy arising from the mesothelial surfaces of the pleura, peritoneum, pericardium, or tunica vaginalis. There are roughly 2000 to 3000 new cases of mesothelioma annually in the United States.1 Although the incidence of this disease peaked in the United States about a decade ago, its incidence in many other parts of the world continues to rise, particularly in regions without sufficient asbestos regulation.2